Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Isoniazid
Drug ID BADD_D01204
Description Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.
Indications and Usage For the treatment of all forms of tuberculosis in which organisms are susceptible.
Marketing Status Prescription; Discontinued
ATC Code J04AC01
DrugBank ID DB00951
KEGG ID D00346
MeSH ID D007538
PubChem ID 3767
TTD Drug ID D09XQF
NDC Product Code 71610-108; 50090-1490; 60687-553; 43063-463; 71052-611; 50090-0370; 12785-0002; 50090-0410; 0527-1109; 53002-2920; 71335-0275; 68788-9405; 71610-395; 0555-0071; 46287-009; 63187-978; 12785-0003; 66639-914; 0781-3056; 0555-0066; 70518-0096; 70518-2576; 51079-083
Synonyms Isoniazid | Isonicotinic Acid Hydrazide | Hydrazide, Isonicotinic Acid | Phthivazide | Phthivazid | Isonicotinic Acid Vanillylidenehydrazide | Acid Vanillylidenehydrazide, Isonicotinic | Vanillylidenehydrazide, Isonicotinic Acid | Ftivazide | Tubazide | Isonex
Chemical Information
Molecular Formula C6H7N3O
CAS Registry Number 54-85-3
SMILES C1=CN=CC=C1C(=O)NN
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
HepatotoxicityN-alpha-acetyltransferase 20P61599Not AvailableNot Available
HepatotoxicityAlbuminP02770Not Available26004706
HepatotoxicityCatalaseP04762Not Available26004706
HepatotoxicityN-alpha-acetyltransferase 20P61599Not Available3691615; 9922980
HepatotoxicityOmega-amidase NIT2Q9JHW2Not Available26004706
HepatotoxicityGlutathione peroxidase 1P04041Not Available26004706
HepatotoxicityAlanine aminotransferase 1P24298Not Available4000989; 707874; 110184
Systemic lupus erythematosusN-alpha-acetyltransferase 20P61599Not Available3691615; 9922980
Systemic lupus erythematosusN-alpha-acetyltransferase 20P61599Not AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Pulmonary fibrosis22.01.02.0060.003324%
Pulmonary oedema22.01.03.003; 02.05.02.0030.025481%
Pyrexia08.05.02.0030.203849%
Rash23.03.13.001--Not Available
Rash erythematous23.03.06.0030.031851%Not Available
Rash generalised23.03.13.0020.012741%Not Available
Rash macular23.03.13.0030.019111%Not Available
Rash maculo-papular23.03.13.0040.063703%
Rash pruritic23.03.12.0020.019111%Not Available
Red man syndrome23.03.06.011; 10.01.01.0130.012741%Not Available
Renal disorder20.01.02.0020.012741%Not Available
Renal failure20.01.03.0050.009971%Not Available
Respiratory acidosis22.02.02.004; 14.01.04.0020.012741%Not Available
Respiratory disorder22.02.07.0020.012741%Not Available
Respiratory distress22.02.01.0120.025481%Not Available
Respiratory failure22.02.06.002; 14.01.04.003--
Restlessness19.11.02.002; 17.02.05.0210.012741%
Rhabdomyolysis15.05.05.0020.197478%
Seizure17.12.03.0010.140146%
Sensory loss17.02.07.0070.003324%Not Available
Sepsis11.01.11.0030.008309%
Septic shock24.06.02.011; 11.01.11.0040.003324%Not Available
Serotonin syndrome17.05.02.004; 15.05.04.016; 12.03.01.0410.019111%Not Available
Shock24.06.02.0020.013294%Not Available
Sideroblastic anaemia01.03.02.009--Not Available
Sinus tachycardia02.03.03.0100.019111%
Skin disorder23.03.03.0070.031851%Not Available
Skin exfoliation23.03.07.0030.025481%Not Available
Skin hyperpigmentation23.05.01.0030.012741%
Skin lesion23.03.03.0100.012741%Not Available
The 8th Page    First    Pre   8 9 10 11 12    Next   Last    Total 12 Pages